XML 16 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating activities    
Net loss $ (3,564,714) $ (2,982,132)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization 10,622 9,217
Stock-based services expense 189,197 254,437
Non-cash interest on convertible notes 51,333 93,623
Non-cash discount amortization on short-term notes and convertible notes 233,224 437,524
Revaluation of premium conversion derivatives 111,195 (104,143)
Revaluation of warrant liability 18,568 146,730
Loss on notes extinguishments 553,447 537,134
Change in assets and liabilities:    
Prepaid expenses (74,574)
Accounts payable and accrued expenses (104,578) 417,937
Net cash used in operating activities (2,576,280) (1,189,673)
Investing activities    
Purchase of intangible assets (65,000) (91,709)
Net cash used in investing activities (65,000) (91,709)
Financing activities    
Proceeds from issuance of convertible promissory notes 564,565
Proceeds from issuance of warrants associated with convertible notes 575,435
Issuance costs related to convertible notes (9,779)
Issuance costs related to warrants (8,670)
Proceeds from issuance of common stock in connection with private placement 3,768,032  
Proceeds from issuance of warrants in connection with private placement 1,416,915
Issuance costs in connection with private placement (617,134)
Exercise of warrants 416,333
Exercise of stock-options 3,273
Proceeds from unsecured loans 245,000 115,000
Repayment of unsecured loans (299,000)
Net cash provided by financing activities 4,933,419 1,236,551
Net increase (decrease) in cash 2,292,139 (44,831)
Cash at beginning of period 13,260 70,029
Cash at end of period 2,305,399 25,198
Supplemental non-cash financing and investing transactions:    
Conversion of convertible promissory notes to equity 1,678,361
Exercise of premium conversion derivative liability 419,590
Reclassification of warrant liability to equity 835,723
Bifurcation of premium conversion derivative related to convertible notes 219,825
Issuance of warrants in connection with convertible notes 117,280
Stock value adjustment associated with intellectual license agreement 299
Change in accounts payable and accrued expenses attributed to private placement and convertible note issuance costs 230,959 14,226
Purchased intangible assets in accrued expenses $ 30,000